A Phase IIa Randomized Controlled Pilot Study Evaluating the Safety and Clinical Outcomes Following the Use of rhGDF-5/β-TCP in Regenerative Periodontal Therapy

Clinical Oral Investigations - Germany
doi 10.1007/s00784-011-0610-3

Related search